Showing results (331-340 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|April 20, 2018
Physiologically-based modeling and interspecies prediction of paclitaxel pharmacokineticsXiaowei Zang, Leonid KaganJournal of Pharmacokinetics and Pharmacodynamics|June 23, 2019
Automated proper lumping for simplification of linear physiologically based pharmacokinetic systemsShan Pan, Stephen B DuffullJournal of Pharmacokinetics and Pharmacodynamics|April 21, 2019
Reproducible pharmacokineticsJohn P A IoannidisJournal of Pharmacokinetics and Pharmacodynamics|May 13, 2019
Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and ratsArmin Sepp, Guy Meno-Tetang, Andrew Weber, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 10, 2018
The use of PBPK modeling across the pediatric age range using propofol as a caseRobin Michelet, Jan Van Bocxlaer, Karel Allegaert, et al.Journal of Pharmacokinetics and Pharmacodynamics|May 31, 2001
Time-dependent oral absorption modelsK Higaki, S Yamashita, G L AmidonJournal of Pharmacokinetics and Pharmacodynamics|May 31, 2001
Is mixed effects modeling or naïve pooled data analysis preferred for the interpretation of single sample per subject toxicokinetic data?J P Hing, S G Woolfrey, D Greenslade, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 20, 2001
Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents, and adultsD M Reith, W D Hooper, J Parke, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
The need for mixed-effects modeling with population dichotomous dataI Yano, S L Beal, L B SheinerJournal of Pharmacokinetics and Pharmacodynamics|July 27, 2001
Assessment of actual significance levels for covariate effects in NONMEMU Wählby, E N Jonsson, M O KarlssonPageof 107